已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer

医学 结直肠癌 内科学 肿瘤科 辅助治疗 癌症 人口 化疗 队列 林奇综合征 阶段(地层学) 胃肠病学 DNA错配修复 生物 环境卫生 古生物学
作者
Jeanne Tie,Joshua David Cohen,Yuxuan Wang,Michael Christie,Koen Simons,Margaret Lee,Rachel Wong,Suzanne Kosmider,Sumitra S. Ananda,Joseph James McKendrick,Belinda Lee,Jin Hee Cho,Ian G. Faragher,Ian T. Jones,Janine Ptak,Mary J. Schaeffer,Natalie Silliman,Lisa Dobbyn,Li Lü,Cristian Tomasetti
出处
期刊:JAMA Oncology [American Medical Association]
卷期号:5 (12): 1710-1710 被引量:745
标识
DOI:10.1001/jamaoncol.2019.3616
摘要

Importance: Adjuvant chemotherapy in patients with stage III colon cancer prevents recurrence by eradicating minimal residual disease. However, which patients remain at high risk of recurrence after completing standard adjuvant treatment cannot currently be determined. Postsurgical circulating tumor DNA (ctDNA) analysis can detect minimal residual disease and is associated with recurrence in colorectal cancers. Objective: To determine whether serial postsurgical and postchemotherapy ctDNA analysis could provide a real-time indication of adjuvant therapy efficacy in stage III colon cancer. Design, Setting, and Participants: This multicenter, Australian, population-based cohort biomarker study recruited 100 consecutive patients with newly diagnosed stage III colon cancer planned for 24 weeks of adjuvant chemotherapy from November 1, 2014, through May 31, 2017. Patients with another malignant neoplasm diagnosed within the last 3 years were excluded. Median duration of follow-up was 28.9 months (range, 11.6-46.4 months). Physicians were blinded to ctDNA results. Data were analyzed from December 10, 2018, through June 23, 2019. Exposures: Serial plasma samples were collected after surgery and after chemotherapy. Somatic mutations in individual patients' tumors were identified via massively parallel sequencing of 15 genes commonly mutated in colorectal cancer. Personalized assays were designed to quantify ctDNA. Main Outcomes and Measures: Detection of ctDNA and recurrence-free interval (RFI). Results: After 4 exclusions, 96 eligible patients were eligible; median patient age was 64 years (range, 26-82 years); 49 (51%) were men. At least 1 somatic mutation was identified in the tumor tissue of all 96 evaluable patients. Circulating tumor DNA was detectable in 20 of 96 (21%) postsurgical samples and was associated with inferior recurrence-free survival (hazard ratio [HR], 3.8; 95% CI, 2.4-21.0; P < .001). Circulating tumor DNA was detectable in 15 of 88 (17%) postchemotherapy samples. The estimated 3-year RFI was 30% when ctDNA was detectable after chemotherapy and 77% when ctDNA was undetectable (HR, 6.8; 95% CI, 11.0-157.0; P < .001). Postsurgical ctDNA status remained independently associated with RFI after adjusting for known clinicopathologic risk factors (HR, 7.5; 95% CI, 3.5-16.1; P < .001). Conclusions and Relevance: Results suggest that ctDNA analysis after surgery is a promising prognostic marker in stage III colon cancer. Postchemotherapy ctDNA analysis may define a patient subset that remains at high risk of recurrence despite completing standard adjuvant treatment. This high-risk population presents a unique opportunity to explore additional therapeutic approaches.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Pz迷惑完成签到,获得积分10
1秒前
林夏发布了新的文献求助10
1秒前
Her关注了科研通微信公众号
1秒前
嘻嘻哈哈的应助被小白采纳,获得10
4秒前
大模型的应助被结实的半双采纳,获得10
4秒前
研友_85rJEL完成签到 ,获得积分10
4秒前
4秒前
吱吱吱吱完成签到 ,获得积分10
5秒前
5秒前
5秒前
7秒前
10秒前
楠楠发布了新的文献求助10
10秒前
甜菜图书馆完成签到,获得积分10
11秒前
专注向雪完成签到 ,获得积分10
13秒前
zhaoxx完成签到 ,获得积分10
13秒前
微笑大神发布了新的文献求助10
14秒前
14秒前
XHQ完成签到 ,获得积分10
14秒前
Alice发布了新的文献求助10
16秒前
17秒前
脑洞疼的应助被DearWhite采纳,获得10
17秒前
浪漫小窗完成签到,获得积分10
17秒前
文献阅读小王完成签到 ,获得积分10
20秒前
ty发布了新的文献求助30
20秒前
Pz迷惑发布了新的文献求助10
22秒前
GJing完成签到 ,获得积分10
25秒前
27秒前
永恒完成签到 ,获得积分10
28秒前
无逾期发布了新的文献求助10
30秒前
gggoblin完成签到,获得积分10
31秒前
王思聪完成签到 ,获得积分10
31秒前
zzzfun完成签到,获得积分10
31秒前
32秒前
小匹夫完成签到 ,获得积分10
33秒前
小兔子完成签到 ,获得积分10
33秒前
Owen的应助被七七四十九采纳,获得10
34秒前
34秒前
科研通AI65的应助被z104采纳,获得10
35秒前
小臣发布了新的文献求助10
36秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8189808
求助须知:如何正确求助?哪些是违规求助? 9576985
关于积分的说明 21850907
捐赠科研通 7787770
什么是DOI,文献DOI怎么找? 3435793
关于科研通互助平台的介绍 2559825
邀请新用户注册赠送积分活动 2482680